BACKGROUND: Celiac sprue is an underdiagnosed chronic intestinal inflammatory disease. Probe-based confocal laser microscopy (CLM) is a novel endoscopic technique for in vivo inspection of the intestinal mucosa that has not been evaluated in celiac sprue yet. AIMS: To develop CLM criteria most predictive of celiac pathology in a prospective pilot study. METHODS:Twenty-one patients (male n = 5, f = 16, mean age 52 years) with established or suspected celiac sprue, seven of whom had confirmed active disease (Marsh III) and 14 duodenal normal mucosa. CLM images from 91 duodenal sites were assessed. CLM recordings were obtained next to Argon beamer labeled areas. Biopsies were taken from the same spots for precise histological matching. After establishing histology-correlated criteria on one sample per patient, the remaining CLM recordings from the same patients were randomized and blindly evaluated. RESULTS:Villous atrophy and irregular appearing villi were most predictive of celiac pathology. Although the presence of crypts was diagnostic for celiac pathology, it was only recognized in 26.7% of celiac pathology sites. Using these criteria in the blinded assessment, the overall endoscopist's prediction of celiac sprue was accurate in 89.8% of all biopsy sites in 85.7% of all patients. Preliminary interobserver agreement testing villous atrophy, irregular villi, and crypts was poor (kappa 0.05 to 0.26). CONCLUSIONS: Probe-based CLM criteria developed in this pilot trial appear promising for the detection of active celiac sprue. Preliminary interobserver variability was high, indicating a learning curve effect. Our criteria need validation in an independent patient population.
RCT Entities:
BACKGROUND: Celiac sprue is an underdiagnosed chronic intestinal inflammatory disease. Probe-based confocal laser microscopy (CLM) is a novel endoscopic technique for in vivo inspection of the intestinal mucosa that has not been evaluated in celiac sprue yet. AIMS: To develop CLM criteria most predictive of celiac pathology in a prospective pilot study. METHODS: Twenty-one patients (male n = 5, f = 16, mean age 52 years) with established or suspected celiac sprue, seven of whom had confirmed active disease (Marsh III) and 14 duodenal normal mucosa. CLM images from 91 duodenal sites were assessed. CLM recordings were obtained next to Argon beamer labeled areas. Biopsies were taken from the same spots for precise histological matching. After establishing histology-correlated criteria on one sample per patient, the remaining CLM recordings from the same patients were randomized and blindly evaluated. RESULTS:Villous atrophy and irregular appearing villi were most predictive of celiac pathology. Although the presence of crypts was diagnostic for celiac pathology, it was only recognized in 26.7% of celiac pathology sites. Using these criteria in the blinded assessment, the overall endoscopist's prediction of celiac sprue was accurate in 89.8% of all biopsy sites in 85.7% of all patients. Preliminary interobserver agreement testing villous atrophy, irregular villi, and crypts was poor (kappa 0.05 to 0.26). CONCLUSIONS: Probe-based CLM criteria developed in this pilot trial appear promising for the detection of active celiac sprue. Preliminary interobserver variability was high, indicating a learning curve effect. Our criteria need validation in an independent patient population.
Authors: Ralf Kiesslich; Liebwin Gossner; Martin Goetz; Alexandra Dahlmann; Michael Vieth; Manfred Stolte; Arthur Hoffman; Michael Jung; Bernhard Nafe; Peter R Galle; Markus F Neurath Journal: Clin Gastroenterol Hepatol Date: 2006-07-13 Impact factor: 11.382
Authors: A Zambelli; V Villanacci; E Buscarini; G Lupinacci; F De Grazia; G Brambilla; F Menozzi; L La Mantia; G Bassotti Journal: Endoscopy Date: 2007-10-10 Impact factor: 10.093
Authors: Heiko Pohl; Thomas Rösch; Barbara T Tanczos; Birgit Rudolph; Karsten Schlüns; Daniel C Baumgart Journal: Gastrointest Endosc Date: 2009-06-27 Impact factor: 9.427
Authors: Y Kakeji; S Yamaguchi; D Yoshida; K Tanoue; M Ueda; A Masunari; T Utsunomiya; M Imamura; H Honda; Y Maehara; M Hashizume Journal: Endoscopy Date: 2006-09 Impact factor: 10.093
Authors: Ralf Kiesslich; Martin Goetz; Katharina Lammersdorf; Constantin Schneider; Juergen Burg; Manfred Stolte; Michael Vieth; Bernhard Nafe; Peter R Galle; Markus F Neurath Journal: Gastroenterology Date: 2007-01-31 Impact factor: 22.682
Authors: Markku Mäki; Kirsi Mustalahti; Jorma Kokkonen; Petri Kulmala; Mila Haapalahti; Tuomo Karttunen; Jorma Ilonen; Kaija Laurila; Ingrid Dahlbom; Tony Hansson; Peter Höpfl; Mikael Knip Journal: N Engl J Med Date: 2003-06-19 Impact factor: 91.245
Authors: F J C van den Broek; P Fockens; S van Eeden; J B Reitsma; J C H Hardwick; P C F Stokkers; E Dekker Journal: Gut Date: 2008-03-26 Impact factor: 23.059
Authors: Do Han Kim; Somashekar G Krishna; Emmanuel Coronel; Paul T Kröner; Herbert C Wolfsen; Michael B Wallace; Juan E Corral Journal: Clin Endosc Date: 2021-11-29